Opthea Stock In The News

OPT Stock  USD 3.33  0.06  1.83%   
Our overall analysis of Opthea's news coverage and content from conventional and social sources shows investors' bearish mood towards Opthea. The specific impact of Opthea news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Opthea's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Opthea headlines in addition to utilizing other, more conventional financial analysis modules. Check out Opthea Backtesting and Opthea Hype Analysis.
For more information on how to buy Opthea Stock please use our How to Invest in Opthea guide.

Opthea Today Top News and Investor Outlook

Yahoo News
Is Opthea (OPT) The Best Australian Stock To Buy According to Hedge Funds?
https://finance.yahoo.com/news/opthea-opt-best-australian-stock-215938047.html
 Bullish
Yahoo News
11 Best ASX Stocks To Buy Now
https://finance.yahoo.com/news/11-best-asx-stocks-buy-115552280.html
 Bullish
Yahoo News
10 Best Australian Stocks To Buy
https://finance.yahoo.com/news/10-best-australian-stocks-buy-081134326.html
 Bullish
Macroaxis News: globenewswire.com
Opthea to Present at the Jefferies 2023 London Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/09/2777079/0/en/Opthea-to-Present-at-the-Jefferies-2023-London-Healthcare-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
https://www.globenewswire.com/news-release/2023/10/30/2768947/0/en/Opthea-to-Present-at-Eyecelerator-Forum-at-the-2023-American-Academy-of-Ophthalmology-AAO-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
https://www.globenewswire.com/news-release/2023/10/27/2768225/0/en/Opthea-Appoints-U-S-Based-Leadership-with-Fred-Guerard-as-CEO-and-Peter-Lang-as-CFO.html
 Bullish
Macroaxis News: globenewswire.com
Opthea to Participate at the 2023 Euretina Congress
https://www.globenewswire.com/news-release/2023/10/02/2752546/0/en/Opthea-to-Participate-at-the-2023-Euretina-Congress.html
 Bullish
Macroaxis News: globenewswire.com
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
https://www.globenewswire.com/news-release/2023/09/07/2739067/0/en/Opthea-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)
https://www.globenewswire.com/news-release/2023/08/28/2732392/0/en/Opthea-Successfully-Completes-Institutional-Offer-and-Increases-Capital-Raising-to-A-90-0m-US-57-6-million.html
 Bullish
Macroaxis News: globenewswire.com
Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
https://www.globenewswire.com/news-release/2023/07/26/2711100/0/en/Opthea-Announces-Sozinibercept-as-the-Nonproprietary-Drug-Name-for-OPT-302.html
 Bullish

Opthea Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Opthea and other traded companies coverage with news coverage. We help investors stay connected with Opthea headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on Opthea Stock performance. Please note that trading solely based on the Opthea hype is not for everyone as timely availability and quick action are needed to avoid losses.
Opthea's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Opthea investors visualize upcoming and past events in order to time the market based on Opthea noise-free hype analysis.
Opthea stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Opthea earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Opthea that are available to investors today. That information is available publicly through Opthea media outlets and privately through word of mouth or via Opthea internal channels. However, regardless of the origin, that massive amount of Opthea data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Opthea news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Opthea relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Opthea's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Opthea alpha.

Opthea Largest EPS Surprises

Earnings surprises can significantly impact Opthea's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-10-30
2024-09-30-0.66-0.75-0.0913 
2024-08-30
2024-06-30-0.54-1.23-0.69127 
2024-02-28
2023-12-31-0.2-0.89-0.69345 
2023-05-31
2023-03-310.13-0.6-0.73561 
2020-12-02
2020-09-300.960.12-0.8487 
2023-11-29
2023-09-30-0.07-1.02-0.951357 
View All Earnings Estimates

Opthea Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Opthea Stock. Current markets are slightly bullish. About 51% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
26th of November 2024
Optheas Wet AMD Program to be Featured at FLORetina 2024
at finance.yahoo.com 
Google News at Macroaxis
19th of November 2024
Opthea Limited Targets AMD Market with Sozinibercept - TipRanks
at news.google.com 
fool News
15th of November 2024
Why Healius, Opthea, Peninsula Energy, and Wildcat shares are falling today
at fool.com.au 
news
14th of November 2024
Eye on the prize 15.9m boost for Optheas vision impairment therapy
at finnewsnetwork.com.au 
Yahoo News
12th of November 2024
Optheas Wet AMD Program Featured at Ophthalmology Events
at finance.yahoo.com 
Yahoo News
21st of October 2024
Ocean Power Technologies Appoints Remah International Group as Distributor in the UAE
at finance.yahoo.com 
Yahoo News
16th of October 2024
Is Opthea Limited the Penny Stock with the Biggest Upside Potential According to Analysts
at finance.yahoo.com 
Macroaxis News: globenewswire.com
10th of October 2024
Opthea Wet AMD Program to be Presented at Innovate Retina
at globenewswire.com 
fool News
4th of October 2024
3 ASX All Ords health care shares that reached 52-week peaks today
at fool.com.au 
Yahoo News
30th of September 2024
Opthea to Participate in the UBS Virtual Ophthalmology Day 2024
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Opthea in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Opthea's short interest history, or implied volatility extrapolated from Opthea options trading.

Additional Tools for Opthea Stock Analysis

When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.